Evidence map›Paper›PMID 12032839›Full record

ArticleOncogene2002

Characterization of a novel hexameric repeat DNA sequence in the promoter of the immediate early gene, IEX-1, that mediates 1alpha,25-dihydroxyvitamin D(3)-associated IEX-1 gene repression.

Hee-Jeong Im, Theodore A Craig, Mark R Pittelkow, Rajiv Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immediate early gene X-1 interacts with proteins that modulate apoptosis.Biochemical and biophysical research communications · 2004
    Article
  8. Article
  9. Article
  10. A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2003
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hee-Jeong ImDepartment of Internal Medicine, Mayo Clinic and Foundation, 200 First Street, SW, Rochester, Minnesota, MN 55905, USA.
Theodore A Craig
Mark R Pittelkow
Rajiv Kumar
Mayo Clinic · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
PATHOGENESIS OF VITAMIN D REFRACTORY DISEASESR01AR027032 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 1986 to 2015
$3.5M
THE PHYSIOLOGY AND METABOLISM OF VITAMIN DR01DK025409 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI KUMAR, RAJIV · 1986 to 2003
$1.0M
Role of Vitamin D in Dendritic Cell Immune FunctionsR01DK059505 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI GRIFFIN, MATTHEW D. · 2001 to 2004
$889k
THE STRUCTURE OF CALBINDIN-D28KR01DK058546 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI KUMAR, RAJIV · 2001 to 2004
$727k
PATHOGENESIS Of VITAMIN D REFRACTORY DISEASESR56AR027032 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2009 to 2009
$378k
NCI NIH HHS CA 015083NIAMS NIH HHS AR27032NIDDK NIH HHS DK25409NIDDK NIH HHS DK58546NIDDK NIH HHS DK59505NIDDK NIH HHS R01 DK025409NIDDK NIH HHS R01 DK058546
6 · The paper itself

Abstract

1alpha,25-Dihydroxyvitamin D(3)(1alpha,25(OH)(2)D(3)), the active metabolite of vitamin D(3), mediates anti-proliferative effects in cells by regulating the expression of 1alpha,25(OH)(2)D(3)-responsive genes. The expression of the proliferation-promoting Immediate Early gene X-1 (IEX-1) is reduced by 1alpha,25(OH)(2)D(3) through unknown mechanisms. Here we report the presence of a novel inhibitory hexameric repeat DNA response element in the promoter of the human IEX-1 gene that mediates 1alpha,25(OH)(2)D(3)-associated IEX-1 gene repression. To localize a vitamin D sensitive DNA response element we transfected the keratinocyte-like cell line, HaCaT, (referred as HaCaT) with a series of plasmids containing full-length and truncated IEX-1 promoter elements fused to the luciferase reporter gene in the absence or presence of 1alpha,25(OH)(2)D(3), and we performed electrophoretic gel mobility assays in the presence of receptors for 1alpha,25(OH)(2)D(3) (vitamin D receptor, VDR) and 9-cis-retinoic acid (RXRalpha). We mapped a negative response element between nt -405 and -391(15 bp) of theIEX-1 promoter (5'-TGAACC AGG GAGTCA-3') that mediates transcriptional inhibition in response to 1alpha,25(OH)(2)D(3) and which requires expression of both nuclear receptors for 1alpha,25(OH)(2)D(3) and 9-cis-retinoic acid. Our data indicate that the physiological repression of IEX-1 gene expression by 1alpha,25(OH)(2)D(3) is directly mediated by nuclear VDR/RXRalpha heterodimers through a specific transcriptional element.

Indexed as

Gene Expression RegulationNeoplasm ProteinsApoptosis Regulatory ProteinsBase SequenceCell LineDimerizationElectrophoretic Mobility Shift AssayHumansImmediate-Early ProteinsMembrane GlycoproteinsMembrane ProteinsMolecular Sequence DataMutagenesis, Site-DirectedMutationPromoter Regions, GeneticReceptors, Retinoic Acid2-methyl-1,25-dihydroxyvitamin D3Apoptosis Regulatory ProteinsIER3 protein, humanImmediate-Early ProteinsMembrane GlycoproteinsMembrane ProteinsNeoplasm ProteinsReceptors, Retinoic AcidRetinoid X ReceptorsTranscription FactorsVitamin D

Identifiers

PMID12032839
OpenAlexW2080664569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.